Skip Nav Destination
Efficacy and safety of imatinib in adult patients with c-kit–positive acute myeloid leukemia
Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia
Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study
Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder
Nicked β2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis
Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies
Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study
Prompt versus preemptive intervention for EBV lymphoproliferative disease
Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell–depleted allografts
Issue Archive
May 15 2004
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
REVIEW ARTICLES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Efficacy and safety of imatinib in adult patients with c-kit–positive acute myeloid leukemia
Clinical Trials & Observations
Thomas Kindler,Frank Breitenbuecher,Andreas Marx,Joachim Beck,Georg Hess,Birgit Weinkauf,Justus Duyster,Christian Peschel,Charles J. Kirkpatrick,Matthias Theobald,Harald Gschaidmeier,Christoph Huber,Thomas Fischer
Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival
Clinical Trials & Observations
Steven Neudorf,Jean Sanders,Nathan Kobrinsky,Todd A. Alonzo,Allen B. Buxton,Stuart Gold,Dorothy R. Barnard,Joetta D. Wallace,Dagmar Kalousek,Beverly J. Lange,William G. Woods
Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas
Clinical Trials & Observations
Florent Grange,Tony Petrella,Marie Beylot-Barry,Pascal Joly,Michel D'Incan,Michele Delaunay,Laurent Machet,Marie-Francoise Avril,Sophie Dalac,Philippe Bernard,Agnes Carlotti,Eric Esteve,Beatrice Vergier,Pierre Dechelotte,Elisabeth Cassagnau,Philippe Courville,Philippe Saiag,Liliane Laroche,Martine Bagot,Janine Wechsler,for the French Study Group on Cutaneous Lymphomas
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia
Clinical Trials & Observations
B. Douglas Smith,Mark Levis,Miloslav Beran,Francis Giles,Hagop Kantarjian,Karin Berg,Kathleen M. Murphy,Tianna Dauses,Jeffrey Allebach,Donald Small
Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity
Clinical Trials & Observations
Sanjay Rajagopalan,Emily C. Somers,Robert D. Brook,Christine Kehrer,Dana Pfenninger,Emily Lewis,Anjan Chakrabarti,Bruce C. Richardson,Eric Shelden,W. Joseph McCune,Mariana J. Kaplan
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
Clinical Trials & Observations
Tarun Kewalramani,Andrew D. Zelenetz,Stephen D. Nimer,Carol Portlock,David Straus,Ariela Noy,Owen O'Connor,Daniel A. Filippa,Julie Teruya-Feldstein,Alison Gencarelli,Jing Qin,Alyson Waxman,Joachim Yahalom,Craig H. Moskowitz
Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study
Clinical Trials & Observations
Robert J. Adams,Donald J. Brambilla,Suzanne Granger,Dianne Gallagher,Elliott Vichinsky,Miguel R. Abboud,Charles H. Pegelow,Gerald Woods,Elizabeth M. Rohde,Fenwick T. Nichols,Anne Jones,Judith P. Luden,Latonya Bowman,Susan Hagner,Knashawn H. Morales,E. Steve Roach,for the STOP Study Investigative Team
Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder
Clinical Trials & Observations
Jean-Christophe Gris,Eric Mercier,Isabelle Quéré,Géraldine Lavigne-Lissalde,Eva Cochery-Nouvellon,Médéric Hoffet,Sylvie Ripart-Neveu,Marie-Laure Tailland,Michel Dauzat,Pierre Marès
ERRATA
GENE THERAPY
HEMATOPOIESIS
Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1–deregulated expression
Ying Zhang,Yuka Nagata,Guangyao Yu,Hao G. Nguyen,Matthew R. Jones,Paul Toselli,Carl W. Jackson,Masaaki Tatsuka,Kazuo Todokoro,Katya Ravid
Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility
Caroline A. Evans,Robert Tonge,David Blinco,Andrew Pierce,Joanne Shaw,Yuning Lu,Hajja G. Hamzah,Alexander Gray,C. Peter Downes,Simon J. Gaskell,Elaine Spooncer,Anthony D. Whetton
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Nicked β2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis
Clinical Trials & Observations
Shinsuke Yasuda,Tatsuya Atsumi,Masahiro Ieko,Eiji Matsuura,Kazuko Kobayashi,Junko Inagaki,Hisao Kato,Hideyuki Tanaka,Minoru Yamakado,Minoru Akino,Hisatoshi Saitou,Yoshiharu Amasaki,Satoshi Jodo,Olga Amengual,Takao Koike
Hepatic low-density lipoprotein receptor–related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol
Sonia M. S. Espirito Santo,Nuno M. M. Pires,Lianne S. M. Boesten,Gery Gerritsen,Niels Bovenschen,Ko Willems van Dijk,J. Wouter Jukema,Hans M. G. Princen,André Bensadoun,Wei-Ping Li,Joachim Herz,Louis M. Havekes,Bart J. M. van Vlijmen
IMMUNOBIOLOGY
IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells
Cristina Tecchio,Veronica Huber,Patrizia Scapini,Federica Calzetti,Daniela Margotto,Giuseppe Todeschini,Lorenzo Pilla,Giovanni Martinelli,Giovanni Pizzolo,Licia Rivoltini,Marco A. Cassatella
NEOPLASIA
Light-chain only multiple myeloma is due to the absence of functional (productive) rearrangement of the IgH gene at the DNA level
Florence Magrangeas,Marie-Laure Cormier,Géraldine Descamps,Nadège Gouy,Laurence Lodé,Marie-Paule Mellerin,Jean-Luc Harousseau,Régis Bataille,Stéphane Minvielle,Hervé Avet-Loiseau,for the Intergroupe Francophone du Myélome
Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies
Clinical Trials & Observations
Natalia L. M. Liem,Rachael A. Papa,Christopher G. Milross,Michael A. Schmid,Mayamin Tajbakhsh,Seoyeon Choi,Carole D. Ramirez,Alison M. Rice,Michelle Haber,Murray D. Norris,Karen L. MacKenzie,Richard B. Lock
PHAGOCYTES
RED CELLS
Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors
Clinical Trials & Observations
Victor R. Gordeuk,Adelina I. Sergueeva,Galina Y. Miasnikova,Daniel Okhotin,Yaroslav Voloshin,Peter L. Choyke,John A. Butman,Katerina Jedlickova,Josef T. Prchal,Lydia A. Polyakova
TRANSPLANTATION
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study
Clinical Trials & Observations
Angela Dispenzieri,Robert A. Kyle,Martha Q. Lacy,Terry M. Therneau,Dirk R. Larson,Matthew F. Plevak,S. Vincent Rajkumar,Rafael Fonseca,Philip R. Greipp,Thomas E. Witzig,John A. Lust,Steven R. Zeldenrust,Denise S. Snow,Susan R. Hayman,Mark R. Litzow,Dennis A. Gastineau,Ayalew Tefferi,David J. Inwards,Ivana N. Micallef,Stephen M. Ansell,Luis F. Porrata,Michelle A. Elliott,Morie A. Gertz
Prompt versus preemptive intervention for EBV lymphoproliferative disease
Clinical Trials & Observations
Brief Report
Hans-Joachim Wagner,Yee Chung Cheng,M. Helen Huls,Adrian P. Gee,Ingrid Kuehnle,Robert A. Krance,Malcolm K. Brenner,Cliona M. Rooney,Helen E. Heslop
Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell–depleted allografts
Brief Report
Peter Lang,Karin Barbin,Tobias Feuchtinger,Johann Greil,Matthias Peipp,Susan J. Zunino,Matthias Pfeiffer,Rupert Handgretinger,Dietrich Niethammer,Georg H. Fey
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4+ effector memory cells relative to central memory cells
Kouhei Yamashita,Uimook Choi,Patricia C. Woltz,Susan F. Foster,Michael C. Sneller,Francis T. Hakim,Daniel H. Fowler,Michael R. Bishop,Steven Z. Pavletic,Marisa Tamari,Kathleen Castro,A. John Barrett,Richard W. Childs,Gabor G. Illei,Susan F. Leitman,Harry L. Malech,Mitchell E. Horwitz
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals